Surgery Partners, Inc. (SGRY) stock
SGRYNasdaqServices-General Medical & Surgical Hospitals, NECFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 5/308% above fair value
$26.95+0.37 (+1.39%)
Close on Nov 13, 2026Market cap $3.53BP/E –Yield –
Surgery Partners ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Surgery Partners's ebitda for the twelve months ending Sep 30, 2026 was $541.00M, down 2.8% year over year. For fiscal 2025 it was $565.50M, up 12.8% from the year before. Over ten years it grew 24.0% a year on average. The highest annual figure on record is $565.50M in fiscal 2025.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $565.50M | +12.8% |
| FY2024 | Dec 31, 2024 | $501.40M | +12.4% |
| FY2023 | Dec 31, 2023 | $446.10M | -3.0% |
| FY2022 | Dec 31, 2022 | $460.00M | +14.7% |
| FY2021 | Dec 31, 2021 | $401.00M | +44.3% |
| FY2020 | Dec 31, 2020 | $277.80M | -11.1% |
| FY2019 | Dec 31, 2019 | $312.40M | +115.2% |
| FY2018 | Dec 31, 2018 | $145.20M | -38.5% |
| FY2016 | Dec 31, 2016 | $236.03M | +31.6% |
| FY2015 | Dec 31, 2015 | $179.30M | +172.2% |
| FY2014 | Dec 31, 2014 | $65.87M | -5.8% |
| FY2013 | Dec 31, 2013 | $69.89M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $125.20M | -13.8% |
| Q2 FY2026 | Jun 30, 2026 | $141.40M | -7.0% |
| Q1 FY2026 | Mar 31, 2026 | $104.30M | +6.2% |
| Q4 FY2025 | Dec 31, 2025 | $170.10M | +5.7% |
| Q3 FY2025 | Sep 30, 2025 | $145.20M | +30.7% |
| Q2 FY2025 | Jun 30, 2025 | $152.00M | +27.1% |
| Q1 FY2025 | Mar 31, 2025 | $98.20M | -10.5% |
| Q4 FY2024 | Dec 31, 2024 | $161.00M | +21.5% |
| Q3 FY2024 | Sep 30, 2024 | $111.10M | -0.4% |
| Q2 FY2024 | Jun 30, 2024 | $119.60M | -2.0% |
| Q1 FY2024 | Mar 31, 2024 | $109.70M | +37.0% |
| Q4 FY2023 | Dec 31, 2023 | $132.50M | +7.0% |
| Q3 FY2023 | Sep 30, 2023 | $111.50M | +7.3% |
| Q2 FY2023 | Jun 30, 2023 | $122.00M | +16.7% |
| Q1 FY2023 | Mar 31, 2023 | $80.10M | -37.3% |
| Q4 FY2022 | Dec 31, 2022 | $123.80M | -10.0% |
| Q3 FY2022 | Sep 30, 2022 | $103.90M | +17.0% |
| Q2 FY2022 | Jun 30, 2022 | $104.50M | +23.4% |
| Q1 FY2022 | Mar 31, 2022 | $127.80M | +42.0% |
| Q4 FY2021 | Dec 31, 2021 | $137.50M | +12.9% |
| Q3 FY2021 | Sep 30, 2021 | $88.80M | +108.5% |
| Q2 FY2021 | Jun 30, 2021 | $84.70M | +24.4% |
| Q1 FY2021 | Mar 31, 2021 | $90.00M | +98.7% |
| Q4 FY2020 | Dec 31, 2020 | $121.80M | +32.4% |
| Q3 FY2020 | Sep 30, 2020 | $42.60M | -45.0% |
| Q2 FY2020 | Jun 30, 2020 | $68.10M | -8.7% |
| Q1 FY2020 | Mar 31, 2020 | $45.30M | -33.8% |
| Q4 FY2019 | Dec 31, 2019 | $92.00M | – |
| Q3 FY2019 | Sep 30, 2019 | $77.40M | +24.8% |
| Q2 FY2019 | Jun 30, 2019 | $74.60M | +23.9% |
| Q1 FY2019 | Mar 31, 2019 | $68.40M | +20.2% |
| Q4 FY2018 | Dec 31, 2018 | -$33.90M | -169.0% |
| Q3 FY2018 | Sep 30, 2018 | $62.00M | +17.4% |
| Q2 FY2018 | Jun 30, 2018 | $60.20M | -23.8% |
| Q1 FY2018 | Mar 31, 2018 | $56.90M | – |
| Q2 FY2017 | Jun 30, 2017 | $49.16M | – |
| Q1 FY2017 | Mar 31, 2017 | $52.83M | – |
| Q4 FY2016 | Dec 31, 2016 | $78.97M | – |
See a number that looks wrong?